Yong-chang Chen
Zhenjiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Retraction Note: RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells.
Journal: Journal of biomedical science
Published: March 12, 2026
Celastrol acts synergistically with afatinib to suppress non-small cell lung cancer cell proliferation by inducing paraptosis.
Journal: Journal of cellular physiology
Published: June 13, 2020
Active PKG II inhibited the growth and migration of ovarian cancer cells through blocking Raf/MEK and PI3K/Akt signaling pathways.
Journal: Bioscience reports
Published: February 15, 2019
The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: July 18, 2016
Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival.
Journal: Oncotarget
Published: March 05, 2016
RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells.
Journal: Journal of biomedical science
Published: June 04, 2015
Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: November 12, 2014
CK-19 mRNA-positive cells in peripheral blood predict treatment efficacy and survival in small-cell lung cancer patients.
Journal: Medical oncology (Northwood, London, England)
Published: August 28, 2013
Prognostic value of EpCAM/MUC1 mRNA-positive cells in non-small cell lung cancer patients.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 24, 2013
Type II, but not type I, cGMP-dependent protein kinase reverses bFGF-induced proliferation and migration of U251 human glioma cells.
Journal: Molecular medicine reports
Published: October 24, 2012
Endogenous cGMP-dependent protein kinase reverses EGF-induced MAPK/ERK signal transduction through phosphorylation of VASP at Ser239.
Journal: Oncology letters
Published: April 24, 2012
Last Updated: 09/26/2026